E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 10/30/2009 in the Prospect News PIPE Daily.

New Issue: Tianyin Pharmaceutical seals $4.99 million private placement of units

By Devika Patel

Knoxville, Tenn., Oct. 30 - Tianyin Pharmaceutical Co., Inc. raised $4.99 million in a private placement of units on Tuesday, according to an 8-K filed Friday with the Securities and Exchange Commission.

The company sold 1,534,570 units of one common share and one fifth-share warrant at $3.25 apiece. The whole warrants are exercisable at $4.50 for three years.

Tripoint Global Equities was the agent.

Tianyin is a pharmaceutical company located in Chengdu, China.

Issuer:Tianyin Pharmaceutical Co., Inc.
Issue:Units of one common share and one fifth-share warrant
Amount:$4,987,500
Units:1,534,570
Price:$3.25
Warrants:One fifth-share warrant per unit
Warrant expiration:Three years
Warrant strike price:$4.50
Agent:Tripoint Global Equities
Settlement date:Oct. 27
Stock symbol:NYSE Alternext: TPI
Stock price:$3.53 at close Oct. 27
Market capitalization:$83.7 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.